Table 1: HCV strains used in the study.
Name | Genotype | Acute/chronic | Neutralization Escape | Citation |
---|---|---|---|---|
P1VA | 1b | chronic/LT | − | (22) |
P1VC | 1b | chronic/LT | − | (22) |
P1VI | 1b | chronic/LT | − | (22) |
P1VK | 1b | chronic/LT | − | (22) |
P1VL | 1b | chronic/LT | + | (22) |
P2VA | 1b | chronic/LT | − | (22) |
P2VD | 1b | chronic/LT | − | (22) |
P2VH | 1b | chronic/LT | + | (22) |
P2VI | 1b | chronic/LT | + | (22) |
P2VJ | 1b | chronic/LT | + | (22) |
P3VA | 1b | chronic/LT | − | (22) |
P3VB | 1b | chronic/LT | − | (22) |
P3VC | 1b | chronic/LT | + | (22) |
P5VD | 1b | chronic/LT | + | (22) |
P5VE | 1b | chronic/LT | + | (22) |
P5VF | 1b | chronic/LT | + | (22) |
P6VD | 1b | chronic/LT | − | (22) |
P6VI | 1b | chronic/LT | + | (22) |
P6VH | 1b | chronic/LT | + | (22) |
UKNP1.3.1 | 1a | acute | N. T. | (32) |
UNKP1.4.1 | 1a | acute | N. T. | (32) |
UKNP1.5.1 | 1a | acute | N. T. | (32) |
UKNP1.5.2 | 1a | acute | N. T. | (32) |
UKNP1.5.3 | 1a | chronic | N. T. | (32) |
UKNP1.6.1 | 1a | acute | N. A, | (32) |
UKN1a.16.16 | 1a | acute | N. T. | This study |
UKNP3.2.1 | 3 | acute | N. T. | (32) |
HCV-J | 1b | chronic | N. T. | (33) |
UKN1A14.38 | 1a | chronic | N. T. | (34) |
UKN3A1.22 | 3a | chronic | N. T. | (34) |
3a SXB | 3a | chronic | N. T. | (35) |